Following unanimous votes by a committee of independent advisors last week, the Food and Drug Administration approved booster doses of the COVID-19 vaccines produced by Moderna and Johnson & Johnson.
In a similar decision, the FDA approved boosters that are not the same as the vaccination used to immunise people against COVID-19. As an example, a person who received a Johnson & Johnson vaccination may obtain a booster from Moderna or Pfizer-BioNTech.
The regulatory changes pave the way for more widespread usage of boosters. The FDA approved a booster dose of the Pfizer COVID-19 vaccine in September.
“The available data suggest waning immunity in some populations who are fully vaccinated,” said the FDA’s acting commissioner, Dr. Janet Woodcock, in a statement. “The availability of these authorized boosters is important for continued protection against COVID-19 disease.”
On Thursday, a committee of advisers to the Centers for Disease Control and Prevention is scheduled to meet to discuss COVID-19 vaccine booster shots and make recommendations on their use. The CDC director makes the final call on vaccine guidelines. After the CDC issues its guidance, the rollout can begin officially.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…